...
首页> 外文期刊>Pharmacology and Therapeutics: The Journal of the International Encyclopedia of Pharmacology and Therapeutics >Cardiac cell volume: crystal clear or murky waters? A comparison with other cell types.
【24h】

Cardiac cell volume: crystal clear or murky waters? A comparison with other cell types.

机译:心脏细胞体积:清澈透明或浑浊的水?与其他单元格类型的比较。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The osmolarity of bodily fluids is strictly controlled so that most cells do not experience changes in osmotic pressure under normal conditions, but osmotic changes can occur in pathological states such as ischemia, septic shock, and diabetic coma. The primary effect of a change in osmolarity is to acutely alter cell volume. If the osmolarity around a cell is decreased, the cell swells, and if increased, it shrinks. In order to tolerate changes in osmolarity, cells have evolved volume regulatory mechanisms activated by osmotic challenge to normalise cell volume and maintain normal function. In the heart, osmotic stress is encountered during a period of myocardial ischemia when metabolites such as lactate accumulate intracellularly and to a certain degree extracellularly, and cause cell swelling. This swelling may be exacerbated further on reperfusion when the hyperosmotic extracellular milieu is replaced by normosmotic blood. In this review, we describe the theory and mechanisms of volume regulation, and draw on findings in extracardiac tissues, such as kidney, whose responses to osmotic change are well characterised. We then describe cell volume regulation in the heart, with particular emphasis on the effect of myocardial ischemia. Finally, we describe the consequences of osmotic cell swelling for the cell and for the heart, and discuss the implications for antiarrhythmic drug efficacy. Using computer modelling, we have summated the changes induced by cell swelling, and predict that swelling will shorten the action potential. This finding indicates that cell swelling is an important component of the response to ischemia, a component modulating the excitability of the heart.
机译:严格控制体液的渗透压,以使大多数细胞在正常条件下不会经历渗透压的变化,但是渗透压变化可以发生在缺血,脓毒性休克和糖尿病昏迷等病理状态。渗透压变化的主要作用是急剧改变细胞体积。如果细胞周围的渗透压降低,则细胞膨胀,如果升高,则收缩。为了耐受渗透压的变化,细胞已经发展了通过渗透挑战激活的体积调节机制,以使细胞体积正常化并维持正常功能。在心脏,心肌缺血期间会遇到渗透压,此时代谢产物(如乳酸)会在细胞内蓄积,并在一定程度上在细胞外蓄积,并引起细胞肿胀。当高渗细胞外环境被正常血液代替时,这种肿胀在再灌注时可能会进一步加剧。在这篇综述中,我们描述了体积调节的理论和机理,并借鉴了心脏外组织如肾脏的发现,这些组织对渗透变化的反应具有良好的特征。然后,我们描述心脏中的细胞体积调节,特别着重于心肌缺血的作用。最后,我们描述了渗透细胞膨胀对细胞和心脏的影响,并讨论了抗心律失常药物功效的含义。使用计算机建模,我们总结了细胞肿胀引起的变化,并预测肿胀会缩短动作电位。这一发现表明,细胞肿胀是对缺血反应的重要组成部分,它是调节心脏兴奋性的组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号